Skip to main content
News

Anti-Inflammatory Drug Recall


October 14, 2016

As reported in the latest US Food and Drug Administration (FDA) Enforcement Report, a voluntary recall of 1-mg PredniSONE tablets USP was initiated by West-Ward Pharmaceuticals on October 3. This nationwide, Class II recall is ongoing.

The reasons cited for this recall of more than 15,000 100-count bottles of the prescription drug are “failed tablet/capsule specifications: discovery of an underweight tablet.”

The recalled PredniSONE tablets have an expiration date of January 31, 2018 and a lot number of 660621A.

The drug is indicated for the treatment of endocrine disorders, rheumatic disorders, and collagen diseases, among others.

—Meredith Edwards White

 

References

https://www.accessdata.fda.gov/scripts/ires/index.cfm

http://www.fda.gov/Safety/Recalls/ucm165546.htm

Back to Top